Industry Research Reports

Home > Reports > Service & Software > Pharmacovigilance Outsourcing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Pharmacovigilance Outsourcing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-07-09

Pages: 117 Pages

Report ld: 6848794

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Pharmacovigilance Outsourcing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

Outsourcing pharmacovigilance activities help biopharmaceutical, pharmaceutical, and biotechnology companies to gain accurate and professional insights on ADRs (Adverse Drug Reactions) for a specific drug before it is marketed.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report provides a comprehensive view of the global market for Pharmacovigilance Outsourcing, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Pharmacovigilance Outsourcing market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Pharmacovigilance Outsourcing.

MARKET SEGMENTATION

By Company

Accenture
Clinquest Group B.V
Cognizant
LabCorp
IBM
ArisGlobal
ICON
ITClinical
iMEDGlobal
Foresight Group International AG
TAKE Solutions
PAREXEL
BioClinica
Wipro
United BioSource

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Contract Research Organizations
Business Processing Outsourcing
In-House
Contract Outsourcing

Segment by Application

Pre-marketing Services
Post-marketing Services

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Pharmacovigilance Outsourcing companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Pharmacovigilance Outsourcing revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Pharmacovigilance Outsourcing revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Pharmacovigilance Outsourcing Product Introduction

1.2 Global Pharmacovigilance Outsourcing Market Size Forecast (2021–2032)

1.3 Pharmacovigilance Outsourcing Market Trends & Drivers

1.3.1 Pharmacovigilance Outsourcing Industry Trends

1.3.2 Pharmacovigilance Outsourcing Market Drivers & Opportunities

1.3.3 Pharmacovigilance Outsourcing Market Challenges

1.3.4 Pharmacovigilance Outsourcing Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Pharmacovigilance Outsourcing Players Revenue Ranking (2025)

2.2 Global Pharmacovigilance Outsourcing Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Pharmacovigilance Outsourcing Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Pharmacovigilance Outsourcing

2.6 Pharmacovigilance Outsourcing Market Competitive Analysis

2.6.1 Pharmacovigilance Outsourcing Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Pharmacovigilance Outsourcing Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharmacovigilance Outsourcing revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Pharmacovigilance Outsourcing Market Classification

3.1 Introduction by Type

3.1.1 Contract Research Organizations

3.1.2 Business Processing Outsourcing

3.1.3 In-House

3.1.4 Contract Outsourcing

3.1.5 Global Pharmacovigilance Outsourcing Sales Value by Type

3.1.5.1 Global Pharmacovigilance Outsourcing Sales Value by Type (2021 vs 2025 vs 2032)

3.1.5.2 Global Pharmacovigilance Outsourcing Sales Value, by Type (2021–2032)

3.1.5.3 Global Pharmacovigilance Outsourcing Sales Value, by Type (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pre-marketing Services

4.1.2 Post-marketing Services

4.2 Global Pharmacovigilance Outsourcing Sales Value by Application

4.2.1 Global Pharmacovigilance Outsourcing Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Pharmacovigilance Outsourcing Sales Value by Application (2021–2032)

4.2.3 Global Pharmacovigilance Outsourcing Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Pharmacovigilance Outsourcing Sales Value by Region

5.1.1 Global Pharmacovigilance Outsourcing Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Pharmacovigilance Outsourcing Sales Value by Region (2021–2026)

5.1.3 Global Pharmacovigilance Outsourcing Sales Value by Region (2027–2032)

5.1.4 Global Pharmacovigilance Outsourcing Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Pharmacovigilance Outsourcing Sales Value, 2021–2032

5.2.2 North America Pharmacovigilance Outsourcing Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Pharmacovigilance Outsourcing Sales Value, 2021–2032

5.3.2 Europe Pharmacovigilance Outsourcing Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Pharmacovigilance Outsourcing Sales Value, 2021–2032

5.4.2 Asia Pacific Pharmacovigilance Outsourcing Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Pharmacovigilance Outsourcing Sales Value, 2021–2032

5.5.2 South America Pharmacovigilance Outsourcing Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Pharmacovigilance Outsourcing Sales Value, 2021–2032

5.6.2 Middle East & Africa Pharmacovigilance Outsourcing Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Pharmacovigilance Outsourcing Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Pharmacovigilance Outsourcing Sales Value, 2021–2032

6.3 United States

6.3.1 United States Pharmacovigilance Outsourcing Sales Value, 2021–2032

6.3.2 United States Pharmacovigilance Outsourcing Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Pharmacovigilance Outsourcing Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Pharmacovigilance Outsourcing Sales Value, 2021–2032

6.4.2 Europe Pharmacovigilance Outsourcing Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Pharmacovigilance Outsourcing Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Pharmacovigilance Outsourcing Sales Value, 2021–2032

6.5.2 China Pharmacovigilance Outsourcing Sales Value by Type (%), 2025 vs 2032

6.5.3 China Pharmacovigilance Outsourcing Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Pharmacovigilance Outsourcing Sales Value, 2021–2032

6.6.2 Japan Pharmacovigilance Outsourcing Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Pharmacovigilance Outsourcing Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Pharmacovigilance Outsourcing Sales Value, 2021–2032

6.7.2 South Korea Pharmacovigilance Outsourcing Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Pharmacovigilance Outsourcing Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Pharmacovigilance Outsourcing Sales Value, 2021–2032

6.8.2 Southeast Asia Pharmacovigilance Outsourcing Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Pharmacovigilance Outsourcing Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Pharmacovigilance Outsourcing Sales Value, 2021–2032

6.9.2 India Pharmacovigilance Outsourcing Sales Value by Type (%), 2025 vs 2032

6.9.3 India Pharmacovigilance Outsourcing Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Accenture

7.1.1 Accenture Profile

7.1.2 Accenture Main Business

7.1.3 Accenture Pharmacovigilance Outsourcing Products, Services, and Solutions

7.1.4 Accenture Pharmacovigilance Outsourcing Revenue (US$ Million), 2021–2026

7.1.5 Accenture Recent Developments

7.2 Clinquest Group B.V

7.2.1 Clinquest Group B.V Profile

7.2.2 Clinquest Group B.V Main Business

7.2.3 Clinquest Group B.V Pharmacovigilance Outsourcing Products, Services, and Solutions

7.2.4 Clinquest Group B.V Pharmacovigilance Outsourcing Revenue (US$ Million), 2021–2026

7.2.5 Clinquest Group B.V Recent Developments

7.3 Cognizant

7.3.1 Cognizant Profile

7.3.2 Cognizant Main Business

7.3.3 Cognizant Pharmacovigilance Outsourcing Products, Services, and Solutions

7.3.4 Cognizant Pharmacovigilance Outsourcing Revenue (US$ Million), 2021–2026

7.3.5 Cognizant Recent Developments

7.4 LabCorp

7.4.1 LabCorp Profile

7.4.2 LabCorp Main Business

7.4.3 LabCorp Pharmacovigilance Outsourcing Products, Services, and Solutions

7.4.4 LabCorp Pharmacovigilance Outsourcing Revenue (US$ Million), 2021–2026

7.4.5 LabCorp Recent Developments

7.5 IBM

7.5.1 IBM Profile

7.5.2 IBM Main Business

7.5.3 IBM Pharmacovigilance Outsourcing Products, Services, and Solutions

7.5.4 IBM Pharmacovigilance Outsourcing Revenue (US$ Million), 2021–2026

7.5.5 IBM Recent Developments

7.6 ArisGlobal

7.6.1 ArisGlobal Profile

7.6.2 ArisGlobal Main Business

7.6.3 ArisGlobal Pharmacovigilance Outsourcing Products, Services, and Solutions

7.6.4 ArisGlobal Pharmacovigilance Outsourcing Revenue (US$ Million), 2021–2026

7.6.5 ArisGlobal Recent Developments

7.7 ICON

7.7.1 ICON Profile

7.7.2 ICON Main Business

7.7.3 ICON Pharmacovigilance Outsourcing Products, Services, and Solutions

7.7.4 ICON Pharmacovigilance Outsourcing Revenue (US$ Million), 2021–2026

7.7.5 ICON Recent Developments

7.8 ITClinical

7.8.1 ITClinical Profile

7.8.2 ITClinical Main Business

7.8.3 ITClinical Pharmacovigilance Outsourcing Products, Services, and Solutions

7.8.4 ITClinical Pharmacovigilance Outsourcing Revenue (US$ Million), 2021–2026

7.8.5 ITClinical Recent Developments

7.9 iMEDGlobal

7.9.1 iMEDGlobal Profile

7.9.2 iMEDGlobal Main Business

7.9.3 iMEDGlobal Pharmacovigilance Outsourcing Products, Services, and Solutions

7.9.4 iMEDGlobal Pharmacovigilance Outsourcing Revenue (US$ Million), 2021–2026

7.9.5 iMEDGlobal Recent Developments

7.10 Foresight Group International AG

7.10.1 Foresight Group International AG Profile

7.10.2 Foresight Group International AG Main Business

7.10.3 Foresight Group International AG Pharmacovigilance Outsourcing Products, Services, and Solutions

7.10.4 Foresight Group International AG Pharmacovigilance Outsourcing Revenue (US$ Million), 2021–2026

7.10.5 Foresight Group International AG Recent Developments

7.11 TAKE Solutions

7.11.1 TAKE Solutions Profile

7.11.2 TAKE Solutions Main Business

7.11.3 TAKE Solutions Pharmacovigilance Outsourcing Products, Services, and Solutions

7.11.4 TAKE Solutions Pharmacovigilance Outsourcing Revenue (US$ Million), 2021–2026

7.11.5 TAKE Solutions Recent Developments

7.12 PAREXEL

7.12.1 PAREXEL Profile

7.12.2 PAREXEL Main Business

7.12.3 PAREXEL Pharmacovigilance Outsourcing Products, Services, and Solutions

7.12.4 PAREXEL Pharmacovigilance Outsourcing Revenue (US$ Million), 2021–2026

7.12.5 PAREXEL Recent Developments

7.13 BioClinica

7.13.1 BioClinica Profile

7.13.2 BioClinica Main Business

7.13.3 BioClinica Pharmacovigilance Outsourcing Products, Services, and Solutions

7.13.4 BioClinica Pharmacovigilance Outsourcing Revenue (US$ Million), 2021–2026

7.13.5 BioClinica Recent Developments

7.14 Wipro

7.14.1 Wipro Profile

7.14.2 Wipro Main Business

7.14.3 Wipro Pharmacovigilance Outsourcing Products, Services, and Solutions

7.14.4 Wipro Pharmacovigilance Outsourcing Revenue (US$ Million), 2021–2026

7.14.5 Wipro Recent Developments

7.15 United BioSource

7.15.1 United BioSource Profile

7.15.2 United BioSource Main Business

7.15.3 United BioSource Pharmacovigilance Outsourcing Products, Services, and Solutions

7.15.4 United BioSource Pharmacovigilance Outsourcing Revenue (US$ Million), 2021–2026

7.15.5 United BioSource Recent Developments

8 Industry Chain Analysis

8.1 Pharmacovigilance Outsourcing Value Chain

8.2 Pharmacovigilance Outsourcing Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Pharmacovigilance Outsourcing Sales Model

8.5.2 Sales Channels

8.5.3 Pharmacovigilance Outsourcing Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Pharmacovigilance Outsourcing Market Trends

Table 2. Pharmacovigilance Outsourcing Market Drivers & Opportunities

Table 3. Pharmacovigilance Outsourcing Market Challenges

Table 4. Pharmacovigilance Outsourcing Market Restraints

Table 5. Global Pharmacovigilance Outsourcing Revenue by Company (US$ Million), 2021–2026

Table 6. Global Pharmacovigilance Outsourcing Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Pharmacovigilance Outsourcing Product Type

Table 9. Key Companies General Availability (GA) Timeline for Pharmacovigilance Outsourcing

Table 10. Global Pharmacovigilance Outsourcing Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharmacovigilance Outsourcing revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Pharmacovigilance Outsourcing Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Pharmacovigilance Outsourcing Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Pharmacovigilance Outsourcing Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Pharmacovigilance Outsourcing Sales Market Share in Value by Type (2021–2026)

Table 17. Global Pharmacovigilance Outsourcing Sales Market Share in Value by Type (2027–2032)

Table 18. Global Pharmacovigilance Outsourcing Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Pharmacovigilance Outsourcing Sales Value by Application (US$ Million), 2021–2026

Table 20. Global Pharmacovigilance Outsourcing Sales Value by Application (US$ Million), 2027–2032

Table 21. Global Pharmacovigilance Outsourcing Sales Market Share in Value by Application (2021–2026)

Table 22. Global Pharmacovigilance Outsourcing Sales Market Share in Value by Application (2027–2032)

Table 23. Global Pharmacovigilance Outsourcing Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 24. Global Pharmacovigilance Outsourcing Sales Value by Region (US$ Million), 2021–2026

Table 25. Global Pharmacovigilance Outsourcing Sales Value by Region (US$ Million), 2027–2032

Table 26. Global Pharmacovigilance Outsourcing Sales Value by Region (%), 2021–2026

Table 27. Global Pharmacovigilance Outsourcing Sales Value by Region (%), 2027–2032

Table 28. Key Countries/Regions Pharmacovigilance Outsourcing Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 29. Key Countries/Regions Pharmacovigilance Outsourcing Sales Value, (US$ Million), 2021–2026

Table 30. Key Countries/Regions Pharmacovigilance Outsourcing Sales Value, (US$ Million), 2027–2032

Table 31. Accenture Basic Information List

Table 32. Accenture Description and Business Overview

Table 33. Accenture Pharmacovigilance Outsourcing Products, Services, and Solutions

Table 34. Revenue (US$ Million) in Pharmacovigilance Outsourcing Business of Accenture (2021–2026)

Table 35. Accenture Recent Developments

Table 36. Clinquest Group B.V Basic Information List

Table 37. Clinquest Group B.V Description and Business Overview

Table 38. Clinquest Group B.V Pharmacovigilance Outsourcing Products, Services, and Solutions

Table 39. Revenue (US$ Million) in Pharmacovigilance Outsourcing Business of Clinquest Group B.V (2021–2026)

Table 40. Clinquest Group B.V Recent Developments

Table 41. Cognizant Basic Information List

Table 42. Cognizant Description and Business Overview

Table 43. Cognizant Pharmacovigilance Outsourcing Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Pharmacovigilance Outsourcing Business of Cognizant (2021–2026)

Table 45. Cognizant Recent Developments

Table 46. LabCorp Basic Information List

Table 47. LabCorp Description and Business Overview

Table 48. LabCorp Pharmacovigilance Outsourcing Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Pharmacovigilance Outsourcing Business of LabCorp (2021–2026)

Table 50. LabCorp Recent Developments

Table 51. IBM Basic Information List

Table 52. IBM Description and Business Overview

Table 53. IBM Pharmacovigilance Outsourcing Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Pharmacovigilance Outsourcing Business of IBM (2021–2026)

Table 55. IBM Recent Developments

Table 56. ArisGlobal Basic Information List

Table 57. ArisGlobal Description and Business Overview

Table 58. ArisGlobal Pharmacovigilance Outsourcing Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Pharmacovigilance Outsourcing Business of ArisGlobal (2021–2026)

Table 60. ArisGlobal Recent Developments

Table 61. ICON Basic Information List

Table 62. ICON Description and Business Overview

Table 63. ICON Pharmacovigilance Outsourcing Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Pharmacovigilance Outsourcing Business of ICON (2021–2026)

Table 65. ICON Recent Developments

Table 66. ITClinical Basic Information List

Table 67. ITClinical Description and Business Overview

Table 68. ITClinical Pharmacovigilance Outsourcing Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Pharmacovigilance Outsourcing Business of ITClinical (2021–2026)

Table 70. ITClinical Recent Developments

Table 71. iMEDGlobal Basic Information List

Table 72. iMEDGlobal Description and Business Overview

Table 73. iMEDGlobal Pharmacovigilance Outsourcing Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Pharmacovigilance Outsourcing Business of iMEDGlobal (2021–2026)

Table 75. iMEDGlobal Recent Developments

Table 76. Foresight Group International AG Basic Information List

Table 77. Foresight Group International AG Description and Business Overview

Table 78. Foresight Group International AG Pharmacovigilance Outsourcing Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Pharmacovigilance Outsourcing Business of Foresight Group International AG (2021–2026)

Table 80. Foresight Group International AG Recent Developments

Table 81. TAKE Solutions Basic Information List

Table 82. TAKE Solutions Description and Business Overview

Table 83. TAKE Solutions Pharmacovigilance Outsourcing Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Pharmacovigilance Outsourcing Business of TAKE Solutions (2021–2026)

Table 85. TAKE Solutions Recent Developments

Table 86. PAREXEL Basic Information List

Table 87. PAREXEL Description and Business Overview

Table 88. PAREXEL Pharmacovigilance Outsourcing Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Pharmacovigilance Outsourcing Business of PAREXEL (2021–2026)

Table 90. PAREXEL Recent Developments

Table 91. BioClinica Basic Information List

Table 92. BioClinica Description and Business Overview

Table 93. BioClinica Pharmacovigilance Outsourcing Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Pharmacovigilance Outsourcing Business of BioClinica (2021–2026)

Table 95. BioClinica Recent Developments

Table 96. Wipro Basic Information List

Table 97. Wipro Description and Business Overview

Table 98. Wipro Pharmacovigilance Outsourcing Products, Services, and Solutions

Table 99. Revenue (US$ Million) in Pharmacovigilance Outsourcing Business of Wipro (2021–2026)

Table 100. Wipro Recent Developments

Table 101. United BioSource Basic Information List

Table 102. United BioSource Description and Business Overview

Table 103. United BioSource Pharmacovigilance Outsourcing Products, Services, and Solutions

Table 104. Revenue (US$ Million) in Pharmacovigilance Outsourcing Business of United BioSource (2021–2026)

Table 105. United BioSource Recent Developments

Table 106. Revenue (US$ Million) in Pharmacovigilance Outsourcing Business of Company 40 (2021–2026)

Table 107. Company 40 Recent Developments

Table 108. Key Raw Materials Lists

Table 109. Key Suppliers of Raw Materials Lists

Table 110. Pharmacovigilance Outsourcing Downstream Customers

Table 111. Pharmacovigilance Outsourcing Distributors List

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

List of Figures

Figure 1. Pharmacovigilance Outsourcing Product Picture

Figure 2. Global Pharmacovigilance Outsourcing Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Pharmacovigilance Outsourcing Sales Value (US$ Million), 2021–2032

Figure 4. Pharmacovigilance Outsourcing Report Years Considered

Figure 5. Global Pharmacovigilance Outsourcing Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Pharmacovigilance Outsourcing Revenue in 2025

Figure 7. Pharmacovigilance Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Contract Research Organizations Picture

Figure 9. Business Processing Outsourcing Picture

Figure 10. In-House Picture

Figure 11. Contract Outsourcing Picture

Figure 12. Global Pharmacovigilance Outsourcing Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Pharmacovigilance Outsourcing Sales Value Market Share by Type, 2025 & 2032

Figure 14. Product Picture of Pre-marketing Services

Figure 15. Product Picture of Post-marketing Services

Figure 16. Global Pharmacovigilance Outsourcing Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Pharmacovigilance Outsourcing Sales Value Market Share by Application, 2025 & 2032

Figure 18. North America Pharmacovigilance Outsourcing Sales Value (US$ Million), 2021–2032

Figure 19. North America Pharmacovigilance Outsourcing Sales Value by Country (%), 2025 vs 2032

Figure 20. Europe Pharmacovigilance Outsourcing Sales Value (US$ Million), 2021–2032

Figure 21. Europe Pharmacovigilance Outsourcing Sales Value by Country (%), 2025 vs 2032

Figure 22. Asia Pacific Pharmacovigilance Outsourcing Sales Value (US$ Million), 2021–2032

Figure 23. Asia Pacific Pharmacovigilance Outsourcing Sales Value by Subregion (%), 2025 vs 2032

Figure 24. South America Pharmacovigilance Outsourcing Sales Value (US$ Million), 2021–2032

Figure 25. South America Pharmacovigilance Outsourcing Sales Value by Country (%), 2025 vs 2032

Figure 26. Middle East & Africa Pharmacovigilance Outsourcing Sales Value (US$ Million), 2021–2032

Figure 27. Middle East & Africa Pharmacovigilance Outsourcing Sales Value by Country (%), 2025 vs 2032

Figure 28. Key Countries/Regions Pharmacovigilance Outsourcing Sales Value (%), 2021–2032

Figure 29. United States Pharmacovigilance Outsourcing Sales Value (US$ Million), 2021–2032

Figure 30. United States Pharmacovigilance Outsourcing Sales Value by Type (%), 2025 vs 2032

Figure 31. United States Pharmacovigilance Outsourcing Sales Value by Application (%), 2025 vs 2032

Figure 32. Europe Pharmacovigilance Outsourcing Sales Value (US$ Million), 2021–2032

Figure 33. Europe Pharmacovigilance Outsourcing Sales Value by Type (%), 2025 vs 2032

Figure 34. Europe Pharmacovigilance Outsourcing Sales Value by Application (%), 2025 vs 2032

Figure 35. China Pharmacovigilance Outsourcing Sales Value (US$ Million), 2021–2032

Figure 36. China Pharmacovigilance Outsourcing Sales Value by Type (%), 2025 vs 2032

Figure 37. China Pharmacovigilance Outsourcing Sales Value by Application (%), 2025 vs 2032

Figure 38. Japan Pharmacovigilance Outsourcing Sales Value (US$ Million), 2021–2032

Figure 39. Japan Pharmacovigilance Outsourcing Sales Value by Type (%), 2025 vs 2032

Figure 40. Japan Pharmacovigilance Outsourcing Sales Value by Application (%), 2025 vs 2032

Figure 41. South Korea Pharmacovigilance Outsourcing Sales Value (US$ Million), 2021–2032

Figure 42. South Korea Pharmacovigilance Outsourcing Sales Value by Type (%), 2025 vs 2032

Figure 43. South Korea Pharmacovigilance Outsourcing Sales Value by Application (%), 2025 vs 2032

Figure 44. Southeast Asia Pharmacovigilance Outsourcing Sales Value (US$ Million), 2021–2032

Figure 45. Southeast Asia Pharmacovigilance Outsourcing Sales Value by Type (%), 2025 vs 2032

Figure 46. Southeast Asia Pharmacovigilance Outsourcing Sales Value by Application (%), 2025 vs 2032

Figure 47. India Pharmacovigilance Outsourcing Sales Value (US$ Million), 2021–2032

Figure 48. India Pharmacovigilance Outsourcing Sales Value by Type (%), 2025 vs 2032

Figure 49. India Pharmacovigilance Outsourcing Sales Value by Application (%), 2025 vs 2032

Figure 50. Pharmacovigilance Outsourcing Value Chain

Figure 51. Pharmacovigilance Outsourcing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Pharmacovigilance Outsourcing market? zhanKai

The top companies in the global Pharmacovigilance Outsourcing market are Accenture、Clinquest Group B.V、Cognizant.

Related Reports

Global Pharmacovigilance Outsourcing Market Research Report 2026
The global Pharmacovigilance Outsourcing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 116
USD 2900.00
(Single User License)
Global Pharmacovigilance Outsourcing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmacovigilance Outsourcing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-25
Pages: 135
USD 4900.00
(Single User License)
Global Pharmacovigilance Outsourcing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmacovigilance Outsourcing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 97
USD 4250.00
(Single User License)
Pharmacovigilance Outsourcing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmacovigilance Outsourcing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 113
USD 3950.00
(Single User License)
Global Pharmacovigilance Outsourcing Market Research Report 2025
The global market for Pharmacovigilance Outsourcing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-21
Pages: 81
USD 2900.00
(Single User License)
Global Pharmacovigilance Outsourcing Market Insights, Forecast to 2030
Outsourcing pharmacovigilance activities help biopharmaceutical, pharmaceutical, and biotechnology companies to gain accurate and professional insights on ADRs (Adverse Drug Reactions) for a specific drug before it is marketed.
Published Date: 2024-04-06
Pages: 110
USD 4900.00
(Single User License)
Global Pharmacovigilance Outsourcing Market Research Report 2024
Outsourcing pharmacovigilance activities help biopharmaceutical, pharmaceutical, and biotechnology companies to gain accurate and professional insights on ADRs (Adverse Drug Reactions) for a specific drug before it is marketed.
Published Date: 2024-01-31
Pages: 99
USD 2900.00
(Single User License)

Global Pharmacovigilance Outsourcing Market Research Report 2026
The global Pharmacovigilance Outsourcing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 116
USD 2900.00 (Single User License)
Global Pharmacovigilance Outsourcing Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmacovigilance Outsourcing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-25
Pages: 135
USD 4900.00 (Single User License)
Global Pharmacovigilance Outsourcing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmacovigilance Outsourcing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 97
USD 4250.00 (Single User License)
Pharmacovigilance Outsourcing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmacovigilance Outsourcing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 113
USD 3950.00 (Single User License)
Global Pharmacovigilance Outsourcing Market Research Report 2025
The global market for Pharmacovigilance Outsourcing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 81
USD 2900.00 (Single User License)
Global Pharmacovigilance Outsourcing Market Insights, Forecast to 2030
Outsourcing pharmacovigilance activities help biopharmaceutical, pharmaceutical, and biotechnology companies to gain accurate and professional insights on ADRs (Adverse Drug Reactions) for a specific drug before it is marketed.
Published: 2024-04-06
Pages: 110
USD 4900.00 (Single User License)
Global Pharmacovigilance Outsourcing Market Research Report 2024
Outsourcing pharmacovigilance activities help biopharmaceutical, pharmaceutical, and biotechnology companies to gain accurate and professional insights on ADRs (Adverse Drug Reactions) for a specific drug before it is marketed.
Published: 2024-01-31
Pages: 99
USD 2900.00 (Single User License)